1789 Capital Oracle LP
1789 Capital Oracle LP is a private investment fund based in Palm Beach, Florida. Its most recent Form D, filed Jul 11, 2025, reports no sales yet. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Christopher Buskirk; Omeed Malik.
- Total raised
- $0Cumulative sales reported on Form D
- Investors
- 0
- First sale
- —
- Minimum investment
- None set
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Christopher Buskirk; Omeed Malik
- Latest Form D
- Jul 11, 2025
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about 1789 Capital Oracle LP
What is the minimum investment for 1789 Capital Oracle LP?
1789 Capital Oracle LP's latest Form D, filed Jul 11, 2025, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in 1789 Capital Oracle LP?
1789 Capital Oracle LP is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has 1789 Capital Oracle LP raised?
1789 Capital Oracle LP's latest Form D, filed Jul 11, 2025, reports no sales yet.
Where is 1789 Capital Oracle LP based?
1789 Capital Oracle LP is based in Palm Beach, Florida.
Size compared with every private investment fund
This fund hasn't reported any sales yet.